Jonathan Zalevsky's Trading History
| NKTRNektar Therapeutics | Aug 20, 2026 | Chief R&D Officer | Informative Sell | 13.39K | $371.99K | |
NKTR Insider Shares: 9.57K (0.03%) | ||||||
You May Also Like
Jonathan Zalevsky insider profile FAQ
What is the percentage of profitable transactions made by Jonathan Zalevsky?
The percentage of profitable transactions made by Jonathan Zalevsky is 44%.
What is the average return per transaction made by Jonathan Zalevsky?
The average return per transaction made by Jonathan Zalevsky is -80.70%.
What stocks does Jonathan Zalevsky hold?
Jonathan Zalevsky holds: NKTR stocks.
What was Jonathan Zalevsky’s latest transaction?
Jonathan Zalevsky’s latest transaction was an Informative Sell of $13.39K.
What was Jonathan Zalevsky's most profitable transaction?
Jonathan Zalevsky’s most profitable transaction was an Informative Sell of NKTR stock on November 18, 2022. The return on the trade was 86.20%.
What is Jonathan Zalevsky's role in Nektar Therapeutics?
Jonathan Zalevsky's role in Nektar Therapeutics is Chief R&D Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.